Artia Global Partners »

Prokidney Corp Shs Cl A shares owned by Artia Global Partners

Quarter-by-quarter ownership of Prokidney Corp Shs Cl A (PROK) shares owned by Artia Global Partners from 13F filings

Historical chart of Artia Global Partners investment in Prokidney Corp Shs Cl A

Tip: Access up to 7 years of quarterly data

All positions including Prokidney Corp Shs Cl A held by Artia Global Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prokidney Corp Shs Cl A by Artia Global Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $4.1M 1.8M 2.24

More positions owned by Artia Global Partners

Insmed Com Par $.01 (INSM)
Abivax Sa Sponsored Ads (ABVX)
Argenx Se Sponsored Adr (ARGX)
Eli Lilly & Co. (LLY)
Proshares Tr Ii Ultra Gold (UGL)
Soleno Therapeutics (SLNO)
Viking Therapeutics (VKTX)
Trevi Therapeutics (TRVI)
Uniqure Nv SHS (QURE)
Newamsterdam Pharma Company Ordinary Shares (NAMS)
Astrazeneca Sponsored Adr
Cidara Therapeutics Com New (CDTX)
Eyepoint Pharmaceuticals Com New (EYPT)
Ionis Pharmaceuticals (IONS)
Dianthus Therapeutics (DNTH)

View all positions for Artia Global Partners

Top funds holding Prokidney Corp Shs Cl A

Suvretta Capital Management
Bleichroeder
Millennium Management
Artia Global Partners
Vanguard Group
Hennion & Walsh Asset Management
BlackRock
Geode Capital Management
Renaissance Technologies
Goldman Sachs Group
Charles Schwab Investment Management
Marshall Wace
Jane Street
Susquehanna International
Woodline Partners

View all funds holding Prokidney Corp Shs Cl A